MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) will report second-quarter 2026 financial results on Aug. 10 and provide investors with a business update as the medical technology company continues to expand its soft-tissue reconstruction business.
The Malvern-based company plans to release earnings before hosting a conference call and webcast at 4:30 p.m. Eastern time on Monday, Aug. 10.
Investors who wish to participate in the conference call must register in advance at https://register-conf.media-server.com/register/BIac7f3df9591c4ff2ad8efda196f608a6. The company recommends registering at least one day before the event or no later than 15 minutes before the call begins.
A live webcast and replay will be available through the Events & Presentations section of the investor relations page on TELA Bio’s website at www.telabio.com.
TELA Bio develops and commercializes soft-tissue reconstruction technologies designed for surgical procedures, with products intended to support tissue repair while reducing reliance on permanent synthetic materials. The company is expected to discuss its quarterly financial performance and provide an update on its business during the investor call.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.